Top Tweets for #CADILA

over 1 year ago

કેડિલા કંપનીમાં રહસ્યમયી દુર્ઘટના, વોશરૂમમાં 4 કર્મચારી બેભાન થયા, મહિલા કર્મચારીનું મોત #Ahmedabad #employees #Cadila #company #fainted #washroom #mystery #BreakingNews https://t.co/rZ1ditQ4dr

0

1

0

298

over 1 year ago

અમદાવાદના ધોળકાની કેડિલા કંપનીમાં મહિલાનું મોત #Ahmedabad #Dholka #Cadila #Gujarat #SandeshNews

0

272

TV13 Gujarati

@tv13gujarati

over 1 year ago

અમદાવાદ : કેડિલા કંપનીમાં 4 કર્મચારીઓ વોશરૂમમાં થયા બેભાન #Ahmedabad #employees #Cadila #company #fainted #washroom #tv13gujarati

tv13gujarati's tweet photo. અમદાવાદ : કેડિલા કંપનીમાં 4 કર્મચારીઓ વોશરૂમમાં થયા બેભાન

#Ahmedabad #employees #Cadila #company #fainted #washroom #tv13gujarati https://t.co/LUWS03JW6S

0

2

0

222

over 1 year ago

Ahmedabad: કેડિલા કંપનીમાં 4 કર્મચારીઓ વોશરૂમમાં થયા બેભાન, 1 મહિલા કર્મચારીનું મોત #Ahmedabad #Gujarat #cadila #cadilacompany https://t.co/1w2giiFPJf વધુ સમાચાર વાંચવા ડાઉનલોડ કરો સંદેશ ન્યૂઝ એપ : https://t.co/9GGo9xr2hO

0

1

0

212

over 1 year ago

Cadilaના રાજીવ મોદી સામે બલ્ગેરિયન યુવતીની હાઈકોર્ટમા ફરિયાદ, તપાસ અટકી ગઈ ! https://t.co/vgxpRrDS0G #gujarat #cadila #rajivmodi #gujarathighcourt #complain #bulgariangirl વધુ સમાચાર વાંચવા ડાઉનલોડ કરો સંદેશ ન્યૂઝ એપ : https://t.co/9GGo9xqusg

0

170

Dr Parveen Yograj

@ParveenYograj

over 1 year ago

FIGHT AGAINST RABIES - In an important breakthrough pharma major Cadila Pharmaceuticals has developed a novel three-dose recombinant nano-particle based rabies G protein vaccine. Aiming at a #Rabies-Free India the novel vaccine was launched by #Cadila with campaign ‘ONE, TWO, THREE. RABIES FREE.’All existing rabies vaccine regimens require five injections spread over 28 days to complete the full regimen. Many animal bite victims are unable to complete the full course of the vaccine due to their complicated dosing schedule, frequent visits to the hospital or clinic and potential loss of income associated with these visits. This leaves many victims unprotected and susceptible to developing rabies, which is a fatal condition. launched in 2022 ThRabis® – Is World’s 1st novel three-dose rabies vaccine. “With this three-dose innovative vaccine, many more lives are being saved – lives that continue to be lost to a preventable disease like Rabies. This vaccine can be a game-changer in our global flight to eliminate rabies through a simpler and more convenient regimen. Continuing journey of making affordable innovations available to the last man in society, #ThRabis® is one more addition to our portfolio of indigenous innovations,”of Cadila Pharmaceuticals. It is estimated that globally, rabies kills 59,000 animal bite victims every year, mainly in Asia and Africa. Over 20,000 people die in India alone, mainly because many animal bite victims do not complete the full course of the available vaccine. ABOUT THRABIS ® The vaccine – ThRabis® is prepared by using Virus-Like Particle technology (VLP). The VLPs self-assemble from this recombinant G protein which is produced from genes cloned into baculovirus expression vectors and expressed in Spodoptera frugiperda (Sf9) insect cells. The vaccine generates antibodies against rabies G protein, which leads to virus neutralisation, as well as prevents virus attachment to the cell to confer protection against rabies. Cadila Pharmaceuticals successfully tested immunogenicity and safety of three doses, i.e. 50 µg (microgram) on days 0, 3 and 7 of the novel vaccine in Phase-I/II and Phase-III clinical trials in healthy volunteers as well as preclinical models. Safety and immunogenicity of the vaccine were established in the trials. Besides being convenient, ThRabis® is an intramuscular vaccine, less painful for recipients. It is also extremely convenient for doctors as it is a ready to use vaccine and does not require reconstitution prior to use (Adding water for injection and mixing it thoroughly). ThRabis® is a major breakthrough vaccine that can help in preventing many rabies related deaths. Unlike other approved rabies vaccines, ThRabis® is a three-dose vaccine and is administered within a week. This ensures clinical effectiveness with just three doses in seven days, and will improve compliance to complete the vaccine course. IN MY CLINICAL PRACTICE I HAVE STARTED USING IT WITH VERY GOOD PATIENT COMPLIANCE AS THERE ARE ONLY 3 DOSES ( 0, 3 , 7 Days) THEM CONVENTIONAL 5 DOSES ( 0, 3, 7, 14, 28 Days) #MedTwitter #MedEd #MedX @IhabFathiSulima @drkeithsiau @Cadila_Pharma

ParveenYograj's tweet photo. FIGHT AGAINST RABIES -
In an important breakthrough pharma major Cadila Pharmaceuticals has developed a novel three-dose recombinant nano-particle based rabies G protein vaccine. Aiming at a #Rabies-Free India the novel vaccine was launched by #Cadila with campaign ‘ONE, TWO, THREE. RABIES FREE.’All existing rabies vaccine regimens require five injections spread over 28 days to complete the full regimen. Many animal bite victims are unable to complete the full course of the vaccine due to their complicated dosing schedule, frequent visits to the hospital or clinic and potential loss of income associated with these visits. This leaves many victims unprotected and susceptible to developing rabies, which is a fatal condition. launched in 2022 ThRabis® – Is World’s 1st novel three-dose rabies vaccine.
“With this three-dose innovative vaccine, many more lives are being saved – lives that continue to be lost to a preventable disease like Rabies. This vaccine can be a game-changer in our global flight to eliminate rabies through a simpler and more convenient regimen. Continuing journey of making affordable innovations available to the last man in society, #ThRabis® is one more addition to our portfolio of indigenous innovations,”of Cadila Pharmaceuticals.
It is estimated that globally, rabies kills 59,000 animal bite victims every year, mainly in Asia and Africa. Over 20,000 people die in India alone, mainly because many animal bite victims do not complete the full course of the available vaccine.
ABOUT THRABIS ®
The vaccine – ThRabis® is prepared by using Virus-Like Particle technology (VLP). The VLPs self-assemble from this recombinant G protein which is produced from genes cloned into baculovirus expression vectors and expressed in Spodoptera frugiperda (Sf9) insect cells. The vaccine generates antibodies against rabies G protein, which leads to virus neutralisation, as well as prevents virus attachment to the cell to confer protection against rabies. Cadila Pharmaceuticals successfully tested immunogenicity and safety of three doses, i.e. 50 µg (microgram) on days 0, 3 and 7 of the novel vaccine in Phase-I/II and Phase-III clinical trials in healthy volunteers as well as preclinical models. Safety and immunogenicity of the vaccine were established in the trials. Besides being convenient, ThRabis® is an intramuscular vaccine, less painful for recipients. It is also extremely convenient for doctors as it is a ready to use vaccine and does not require reconstitution prior to use (Adding water for injection and mixing it thoroughly).
ThRabis® is a major breakthrough vaccine that can help in preventing many rabies related deaths. Unlike other approved rabies vaccines, ThRabis® is a three-dose vaccine and is administered within a week. This ensures clinical effectiveness with just three doses in seven days, and will improve compliance to complete the vaccine course.
IN MY CLINICAL PRACTICE I HAVE STARTED USING IT WITH VERY GOOD PATIENT COMPLIANCE AS THERE ARE ONLY 3 DOSES ( 0, 3 , 7 Days) THEM CONVENTIONAL 5 DOSES ( 0, 3, 7, 14, 28 Days)
#MedTwitter #MedEd #MedX
@IhabFathiSulima @drkeithsiau
@Cadila_Pharma

3

26

12

7

3K

about 2 years ago

Ahmedabad: કેડિલાના માલિક રાજીવ મોદીની મુશ્કેલીમાં વધારો, કોર્ટે આપ્યા ફરીથી તપાસના આદેશ #Ahmedabad #rajivmodi #cadila https://t.co/u4ngOwkP1B વધુ સમાચાર વાંચવા ડાઉનલોડ કરો સંદેશ ન્યૂઝ એપ : https://t.co/9GGo9xqusg

0

1

0

260

about 2 years ago

Ahmedabadમાં કેડીલાના માલિક રાજીવ મોદી કેસમાં સેશન્સ કોર્ટ 3 જુને ચુકાદો આપશે https://t.co/yh9c6QgH3g #ahmedabad #cadila #rajivmodi #court #judgment વધુ સમાચાર વાંચવા ડાઉનલોડ કરો સંદેશ ન્યૂઝ એપ : https://t.co/9GGo9xr2hO

0

219

over 2 years ago

કેડિલાના માલિક રાજીવ મોદીની મુશ્કેલી વધી, બલ્ગેરિયન યુવતી બાદ હવે 100 કર્મચારી પહોંચ્યા કોર્ટમાં #cadila #rajivmodi #pharmaceutical #breakingnews #sexualharrasment #GujaratiNews #rajivmodicase #layoffs #employee https://t.co/d1ZanZ0LgB

0

3

1

0

561

Vibes of India @vibesofindia_

over 2 years ago

કેડિલાના રાજીવ મોદીની મુશ્કેલી વધી, બલ્ગેરિયન યુવતીએ પેનડ્રાઈવમાં કોર્ટને આપ્યા મોટા પુરાવા #cadila #rajivmodi #pharmaceutical #breakingnews #sexualharrasment #GujaratiNews #rajivmodicase #GujaratPolice #ahmedabadpolice https://t.co/eAB5hLYqDi

0

3

2

0

615

Gujarat First

@GujaratFirst

over 2 years ago

કેડિલાના MD રાજીવ મોદીની મુશ્કેલી વધી પીડિતાએ હ્યુમન રાઈટ કાઉન્સિલમાં કરી ફરિયાદ પોલીસે તપાસમાં રાજીવ મોદીને આપી છે ક્લીનચિટ દુષ્કર્મ કેસમાં યુવતીએ ખખડાવ્યા હતા HCના દ્વાર @GujaratFirst #Cadila #RajivModi #HumanRightCouncil #GujaratHighcourt #Ahmedabad

GujaratFirst's tweet photo. કેડિલાના MD રાજીવ મોદીની મુશ્કેલી વધી પીડિતાએ હ્યુમન રાઈટ કાઉન્સિલમાં કરી ફરિયાદ પોલીસે તપાસમાં રાજીવ મોદીને આપી છે ક્લીનચિટ દુષ્કર્મ કેસમાં યુવતીએ ખખડાવ્યા હતા HCના દ્વાર

@GujaratFirst
#Cadila #RajivModi #HumanRightCouncil #GujaratHighcourt #Ahmedabad https://t.co/3DaZ34AKax

0

6

0

297

Deepal.‏‎‎Trivedi

@DeepalTrevedie

over 2 years ago

#Gujarat #Cadila

over 2 years ago

Cadila Pharma's Rajiv Modi is emerging as a sinister woman abuser. After his acrimonious divorce followed by an abuse complaint by a Bulgarian employee, now another employee has come forward charging him with sexual harrasment.He is on bail right now. #Gujarat #CadilaPharma https://t.co/ERP2uRQMy1

0

7

0

1

1K

2

4

2

0

723

Tv9 Gujarati

@tv9gujarati

over 2 years ago

અમદાવાદઃ કેડિલાના રાજીવ મોદી સામેના આરોપો મામલે જિલ્લા સેશન્સ કોર્ટમાં યુવતીની ફરિયાદ પર સુનાવણી | TV9Gujarati #ahmedabad #cadila #rajivmodi #sessionscourt #hearing #gujarat #tv9gujarati

0

412

over 2 years ago

પીડિતાએ રાજીવ મોદી સામે ગ્રામ્ય કોર્ટમાં કરી અરજી #Ahmedabad #Cadila #RajivModi #Gujarat https://t.co/QFYz4ACdqI વધુ સમાચાર વાંચવા ડાઉનલોડ કરો સંદેશ ન્યૂઝ એપ : https://t.co/9GGo9xqusg

0

263